Lazzaro, Carlo http://orcid.org/0000-0003-4795-1834
Article History
Received: 3 March 2024
Accepted: 18 June 2024
First Online: 25 June 2024
Declarations
:
: Carlo Lazzaro has no conflicts of interest/competing interests with this Letter to the Editor. Outside this Letter to the Editor, in the past three years Carlo Lazzaro has received teaching fees from University of Pavia, research grants, speaker or consultancy fees from argenx BV, AstraZeneca S.p.A, Ipsen S.p.A., Janssen-Cilag SPA, Horizon Therapeutics srl, Roche S.p.A., Roche Diagnostics S.p.A., Sanofi s.r.l., Santen GmbH.
: Carlo Lazzaro declares that no section of this Letter to the Editor was supported by Artificial Intelligence.
: This contribution was exempt from ethical review due to it being a Letter to the Editor.